Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350363 · ClinicalTrials.gov registry record · Phase 4
One Hour Preoperative Gatifloxacin
A Phase 4 study of Ophthalmic Surgery, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00350363: Completed Phase 4 study of Ophthalmic Surgery, sponsored by Stanford University.
NCT00350363 is a Phase 4 study of Ophthalmic Surgery that has completed, run by Stanford University. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00350363, a Phase 4 study of Ophthalmic Surgery, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of 1 day versus 1 hour application of topical Zymar.
Conditions Studied
Interventions
- DRUG Zymar
Study Locations (1)
California
- Stanford - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT00350363 record still lists
NCT00350363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Ophthalmic Surgery appearing as the primary indexed condition, and to 1 intervention - of which Zymar is the first listed.
NCT00350363 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00350363 about?
NCT00350363 is a clinical study titled "One Hour Preoperative Gatifloxacin". Comparison of 1 day versus 1 hour application of topical Zymar.
What is the current status of trial NCT00350363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-01. Estimated completion is 2010-12.
What conditions does trial NCT00350363 study?
This clinical trial studies the following conditions: Ophthalmic Surgery.
What interventions are being tested in trial NCT00350363?
The interventions under investigation include: Zymar (DRUG).
Who is sponsoring clinical trial NCT00350363?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00350363 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00350363's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia